Metformin transporters OCT1, OCT2, OCT3, and P-glycoprotein were linked to therapeutic failure in a recent pharmacogenetics investigation of Mexican individuals with type 2 diabetes [19]. The gene discussed is SLC22A3; the disease is type 2 diabetes mellitus.